Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Pharmacology|April 21, 2005
New adenosine A2A receptor antagonists: actions on Parkinson's disease modelsAnnalisa Pinna, Rosaria Volpini, Gloria Cristalli, et al.
The International Journal of Neuropsychopharmacology|October 22, 2013
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the affective properties of drugs of abuseNicola Simola, Lucia Frau, Antonio Plumitallo, et al.
Neurology|December 10, 2003
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated ratsAnna R Carta, Annalisa Pinna, Elisabetta Tronci, et al.
Neurotoxicology|July 26, 2016
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brainLucia Frau, Nicola Simola, Pier Francesca Porceddu, et al.
Experimental Neurology|May 11, 2010
Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expressionAnna R Carta, Lucia Frau, Annalisa Pinna, et al.
Parkinson'S Disease|July 4, 2012
A(2A) Receptor Antagonism and Dyskinesia in Parkinson's DiseaseMicaela Morelli, Fabio Blandini, Nicola Simola, et al.
Synapse (New York, N.Y.)|April 16, 2002
Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated ratsAnna R Carta, Annalisa Pinna, Omar Cauli, et al.
The EPMA Journal|December 4, 2012
Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacySilvia A Mandel, Micaela Morelli, Ilan Halperin, et al.
Neurotoxicity Research|June 3, 2016
Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine AdministrationPier Francesca Porceddu, Ismail Ogunbayode Ishola, Liliana Contu, et al.
Neuropharmacology|July 6, 2021
Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistAnnalisa Pinna, Giulia Costa, Marcello Serra, et al.
Pageof 12